Citi analyst Patrick Donnelly lowered the firm’s price target on Icon (ICLR) to $215 from $290 and keeps a Buy rating on the shares as part of a ...

TD Cowen downgraded Icon (ICLR) to Hold from Buy with a price target of $157, down from $254. The firm entered 2025 “more optimistically,” ...

BofA analyst Michael Ryskin lowered the firm’s price target on Icon (ICLR) to $204 from $255 and keeps a Buy rating on the shares. Sentiment ...

IQVIA (IQV) stock, ICON (ICLR) stock, and Fortrea (FTRE) stock were downgraded at Barclays, citing impact from potential pharma tariffs. Read more here.

Short positions announced for FTAI, revenue updates for MRNA, and price forecasts changed for GME, SNAP, RKLB, NTRA, LLY, ICLR, BNTX, NVO, and BMRN. Lekha Gupta Clinical Research Firm ICON Faces ...

Covered call ETFs can help investors earn steady income while potentially outperforming in range-bound market conditions.

However, he adds, the trade-off is that the upside potential is capped by the strike price of the call. Covered calls tend to work well with stable or moderately volatile stocks. The strategy can ...